Simplex Trading
EBS icon

Simplex Trading’s Emergent Biosolutions EBS Stock Holding History

Simplex Trading’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$725K Buy
86,500
+2,900
+3% +$24.3K ﹤0.01% 3155
2026
Q1 		$694K Sell
83,600
-24,800
-23% -$257K ﹤0.01% 2897
2025
Q4 		$1.34M Buy
108,400
+60,400
+126% +$647K ﹤0.01% 2333
2025
Q3 		$423K Sell
48,000
-1,900
-4% -$14.8K ﹤0.01% 4039
2025
Q2 		$318K Buy
49,900
+43,800
+718% +$251K ﹤0.01% 4005
2025
Q1 		$29K Sell
6,100
-78,600
-93% -$651K ﹤0.01% 6267
2024
Q4 		$809K Sell
84,700
-81,600
-49% -$749K ﹤0.01% 3051
2024
Q3 		$1.39M Buy
166,300
+112,300
+208% +$1.02M ﹤0.01% 2596
2024
Q2 		$368K Buy
54,000
+38,300
+244% +$165K ﹤0.01% 3990
2024
Q1 		$39K Sell
15,700
-6,200
-28% -$14K ﹤0.01% 6490
2023
Q4 		$52K Buy
21,900
+4,900
+29% +$11.5K ﹤0.01% 6043
2023
Q3 		$57K Buy
17,000
+11,100
+188% +$61.5K ﹤0.01% 5677
2023
Q2 		$43K Buy
5,900
+2,200
+59% +$20.4K ﹤0.01% 5987
2023
Q1 		$38K Buy
3,700
+1,100
+42% +$13.3K ﹤0.01% 6228
2022
Q4 		$30K Sell
2,600
-100
-4% -$1.55K ﹤0.01% 6458
2022
Q3 		$56K Sell
2,700
-16,500
-86% -$459K ﹤0.01% 6273
2022
Q2 		$595K Buy
19,200
+16,600
+638% +$567K ﹤0.01% 3228
2022
Q1 		$106K Sell
2,600
-4,500
-63% -$198K ﹤0.01% 6047
2021
Q4 		$308K Buy
7,100
+4,600
+184% +$208K ﹤0.01% 4521
2021
Q3 		$160K Hold
2,500
– – ﹤0.01% 5950
2021
Q2 		$157K Buy
2,500
+2,349
+1,556% +$151K ﹤0.01% 6066
2021
Q1 		$1.4M Buy
+151
New +$15.5K ﹤0.01% 2028
2020
Q4 		– Sell
-30
Closed -$309K – 8491
2020
Q3 		$309K Buy
30
+9
+43% +$970 ﹤0.01% 3568
2020
Q2 		$166K Buy
21
+20
+2,000% +$1.49K ﹤0.01% 4204
2020
Q1 		$5K Sell
1
-3
-75% -$173 ﹤0.01% 6821
2019
Q4 		$21K Sell
4
-7
-64% -$380 ﹤0.01% 5909
2019
Q3 		$57K Hold
11
– – ﹤0.01% 4892
2019
Q2 		$53K Buy
11
+1
+10% +$48 ﹤0.01% 4798
2019
Q1 		$50K Buy
+10
New +$590 ﹤0.01% 4999
2018
Q4 		– Sell
-19
Closed -$125K – 7165
2018
Q3 		$125K Buy
+19
New +$1.11K ﹤0.01% 4188
2018
Q2 		– Sell
-9
Closed -$6K – 7463
2018
Q1 		$6K Sell
9
-40
-82% -$1.99K ﹤0.01% 4457
2017
Q4 		$5K Buy
49
+15
+44% +$631 ﹤0.01% 4480
2017
Q3 		$8K Buy
34
+26
+325% +$941 ﹤0.01% 3970
2017
Q2 		$2K Sell
8
-7
-47% -$216 ﹤0.01% 5214
2017
Q1 		$4K Buy
15
+5
+50% +$152 ﹤0.01% 4748
2016
Q4 		$9K Buy
10
+4
+67% +$120 ﹤0.01% 3830
2016
Q3 		$1K Buy
+6
New +$174 ﹤0.01% 5290
2016
Q2 		– Sell
-10
Closed -$4K – 5924
2016
Q1 		$4K Buy
+10
New +$353 ﹤0.01% 4233
2015
Q3 		– Sell
-2
Closed -$1K – 5642
2015
Q2 		$1K Buy
+2
New +$62 ﹤0.01% 4617

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Simplex Trading's EBS Position: Q4 2025 in Review

Simplex Trading sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 5,932 shares — an estimated $63.6K sold.

Simplex Trading first reported a position in EBS in Q2 2015 and held it in 26 quarters. The position peaked at $694K in Q3 2020. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Simplex Trading reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 5,932 Emergent Biosolutions shares in Q4 2025, an estimated $63.6K.
  • Simplex Trading first reported a position in Emergent Biosolutions in Q2 2015 and held it in 26 quarters.
  • Simplex Trading's Emergent Biosolutions position peaked at $694K in Q3 2020.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.